Registration for this program is made available only through the DCAT Website. There is NO CHARGE for the program but registration is REQUIRED. Seating is limited and registration is on a first-come, first-served basis. Your email address is required for confirmation of your registration. A Name badge will be prepared for you and provided at the registration area that morning.
| 8:30 |
|
Registration & Coffee |
| 9:00 |
|
Opening remarks – Joseph Colleluori, DCAT President, Lonza Inc. |
| 9:05 |
|
Chairman's introduction |
| 9:10 |
|
Evolving Growth Dynamics: Future Impact on Pharma Business Models to 2010 & Beyond
Speaker: John MacCarthy, Vice President, Client Thought Leadership, Global Business Management, IMS Health
- Identifying growth opportunities
- Impact of emerging markets
- Evolution of pharma business models
|
| 9:50 |
|
The Changing Landscape of the Generics Pharmaceutical Market
Speaker: Tommy Erdei, CFA Executive Director, Global healthcare group, UBS Investment Bank
- Operational dynamics of the sector
- Impact on strategy
- M&A environment and expectations
|
| 10:30 |
|
Break |
| |
|
|
| 10:45 |
|
New Demands on Custom Manufactures: Who are the Best Future Partners?
Speaker: Mark Seidler, Principal, SDG LifeSciences, a Unit of IMS
- Change of fortunes & underlying key drivers
- Critical success factors - who is winning and why?
- Characteristics of an ideal partner for pharma
|
| 11:20 |
|
Assessing the Continuing impact of Changes in the Lifecycle of Pharmaceuticals
Speaker: Carl Fearn, Area Vice President, Australia and New Zealand
- Established biotechnology based treatments and their growing importance
- Emergence of Specialty Blockbusters - the Oncology Challenge
- R & D output, what's on the Horizon?
|
| 12:00 |
|
Chair's closing remarks |
| |
|
|
